Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Tolerability and Safety of Low Dose Primaquine for Transmission Blocking in Symptomatic Falciparum Infected Cambodians

NCT02434952 is registered in ClinicalTrials.gov with Malaria Consortium as lead sponsor.

NCT NCT02434952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02434952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Tolerability and Safety of Low Dose Primaquine for Transmission Blocking in Symptomatic Falciparum Infected Cambodians
Lead sponsor
Malaria Consortium
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2014
Completion date
Not reported
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

g6pd deficiency, malaria, falciparum